Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls.
Past and recent attempts at devising objective biomarkers for traumatic brain injury (TBI) in both blood and cerebrospinal fluid have focused on abundance measures of time-dependent proteins. Similar independent determinants would be most welcome in diagnosing the most common form of TBI, mild TBI (...
Main Authors: | Massimo S Fiandaca, Mark Mapstone, Amin Mahmoodi, Thomas Gross, Fabio Macciardi, Amrita K Cheema, Kian Merchant-Borna, Jeffrey Bazarian, Howard J Federoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5909890?pdf=render |
Similar Items
-
Potential Metabolomic Linkage in Blood between Parkinson’s Disease and Traumatic Brain Injury
by: Massimo S. Fiandaca, et al.
Published: (2018-09-01) -
Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
by: Massimo S. Fiandaca, et al.
Published: (2012-06-01) -
Plasma microRNA markers of upper limb recovery following human stroke
by: Matthew A. Edwardson, et al.
Published: (2018-08-01) -
Shannon and Renyi entropies to classify effects of Mild Traumatic Brain Injury on postural sway.
by: Jianbo Gao, et al.
Published: (2011-01-01) -
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
by: Mark Mapstone, et al.
Published: (2020-01-01)